Maruyama J - Search Results

1

The Importance of Lassa Fever and Its Disease Management in West Africa.

Reyna RA, Littlefield KE, Shehu N, Makishima T, Maruyama J, Paessler S. Reyna RA, et al. Among authors: maruyama j. Viruses. 2024 Feb 7;16(2):266. doi: 10.3390/v16020266. Viruses. 2024. PMID: 38400041 Free PMC article. Review.

2

Review of Mammarenavirus Biology and Replication.

Hallam SJ, Koma T, Maruyama J, Paessler S. Hallam SJ, et al. Among authors: maruyama j. Front Microbiol. 2018 Aug 3;9:1751. doi: 10.3389/fmicb.2018.01751. eCollection 2018. Front Microbiol. 2018. PMID: 30123198 Free PMC article.

3

Current small animal models for LASV hearing loss.

Sattler RA, Maruyama J, Shehu NY, Makishima T, Paessler S. Sattler RA, et al. Among authors: maruyama j. Curr Opin Virol. 2019 Aug;37:118-122. doi: 10.1016/j.coviro.2019.08.001. Epub 2019 Aug 31. Curr Opin Virol. 2019. PMID: 31479989 Free PMC article. Review.

4

Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation.

Maruyama J, Manning JT, Mateer EJ, Sattler R, Bukreyeva N, Huang C, Paessler S. Maruyama J, et al. mSphere. 2019 Sep 25;4(5):e00428-19. doi: 10.1128/mSphere.00428-19. mSphere. 2019. PMID: 31554720 Free PMC article.

5

Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.

Maruyama J, Mateer EJ, Manning JT, Sattler R, Seregin AV, Bukreyeva N, Jones FR, Balint JP, Gabitzsch ES, Huang C, Paessler S. Maruyama J, et al. Vaccine. 2019 Oct 23;37(45):6824-6831. doi: 10.1016/j.vaccine.2019.09.030. Epub 2019 Sep 24. Vaccine. 2019. PMID: 31561999 Free PMC article.

6

Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.

Mateer EJ, Maruyama J, Card GE, Paessler S, Huang C. Mateer EJ, et al. Among authors: maruyama j. J Virol. 2020 Apr 16;94(9):e02006-19. doi: 10.1128/JVI.02006-19. Print 2020 Apr 16. J Virol. 2020. PMID: 32051278 Free PMC article.

7

Antiviral activities of type I interferons to SARS-CoV-2 infection.

Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C. Mantlo E, et al. Among authors: maruyama j. Antiviral Res. 2020 Jul;179:104811. doi: 10.1016/j.antiviral.2020.104811. Epub 2020 Apr 29. Antiviral Res. 2020. PMID: 32360182 Free PMC article.

8

Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection.

Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C. Mantlo E, et al. Among authors: maruyama j. bioRxiv [Preprint]. 2020 Apr 5:2020.04.02.022764. doi: 10.1101/2020.04.02.022764. bioRxiv. 2020. Update in: Antiviral Res. 2020 Jul;179:104811. doi: 10.1016/j.antiviral.2020.104811 PMID: 32511327 Free PMC article. Updated. Preprint.

9

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.

Saito T, Maruyama J, Nagata N, Isono M, Okuya K, Takadate Y, Kida Y, Miyamoto H, Mori-Kajihara A, Hattori T, Furuyama W, Ogawa S, Iida S, Takada A. Saito T, et al. Among authors: maruyama j. Viruses. 2020 Aug 22;12(9):923. doi: 10.3390/v12090923. Viruses. 2020. PMID: 32842671 Free PMC article.

10

A single mutation (V64G) within the RING Domain of Z attenuates Junin virus.

Hallam SJ, Manning JT, Maruyama J, Seregin A, Huang C, Walker DH, de la Torre JC, Paessler S. Hallam SJ, et al. Among authors: maruyama j. PLoS Negl Trop Dis. 2020 Sep 25;14(9):e0008555. doi: 10.1371/journal.pntd.0008555. eCollection 2020 Sep. PLoS Negl Trop Dis. 2020. PMID: 32976538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

396 results

Search Page

Filters